Zenzedi — Medica

Attention Deficit Hyperactivity Disorder

Initial criteria

Patient is ≥ 18 years of age AND meets one of the following:
1. Attention Deficit Hyperactivity Disorder (approve for 1 year).
OR
2. Binge Eating Disorder (approve only Vyvanse [brand or generic] for 1 year if patient is > 18 years).
OR
3. Narcolepsy (approve for 1 year).
OR
4. Depression, adjunctive/augmentation treatment in an adult (approve for 1 year if patient is concurrently receiving other medication therapy for depression).
OR
5. Fatigue associated with cancer and/or its treatment (approve for 1 year).
OR
6. Idiopathic hypersomnolence (approve for 1 year if diagnosis is confirmed by a sleep specialist physician or sleep center).

Same criteria as initial approval; reapproval may be granted if current clinical rationale remains and indication continues to meet approval criteria.

1 year